Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErkan, Buruç
dc.contributor.authorBarut, Ozan
dc.contributor.authorÇolluoğlu, Barış
dc.contributor.authorKılıç, Mustafa
dc.contributor.authorAdilay, Hüseyin Utku
dc.contributor.authorGüçlü, Doğan Güçlühan
dc.contributor.authorHaşimoğlu, Ozan
dc.date.accessioned2024-02-05T15:58:27Z
dc.date.available2024-02-05T15:58:27Z
dc.date.issued2023
dc.identifier.issn2630-5720
dc.identifier.urihttps://doi.org/10.14744/hnhj.2022.99076
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1176024
dc.identifier.urihttps://hdl.handle.net/20.500.12462/14071
dc.description.abstractIntroduction: In this study, it was aimed to determine OX40 gene expression level on pathology sections obtained from PA tissues, and the level of circulating OX40L in peripheral blood samples of patients. Furthermore, it was aimed to evaluate the findings depending on the type, histopathological, and immunohistochemical features of the tumor. Methods: The study was conducted with two groups (Study/Control). The study group (Group 1) consisted of patients (n=49) operated with the diagnosis of PA. The control group (Group 2) is the brain tissue samples obtained from patients (n=10) who underwent temporal lobectomy for the and treatment of epilepsy due to mesial temporal sclerosis. Results: We found out that the tissue OX-40 gene expression levels of patients with PA did not differ from the gene expres- sion levels of the control group. There was no statistically significant difference was found as a result of the comparison of pituitary ox40-tissue parameter measurement value with patient finding characteristics. Discussion and Conclusion: PAs have altered cell behavior and epigenetic modifications that lead to various prognostic patterns and responses to treatment. As the disease progresses, up-and down-regulation of immune factors promotes the interaction between the immune system and tumor cells. Thus, it serves as a potential target for new diagnostic and thera- peutic strategies.en_US
dc.language.isoengen_US
dc.relation.ispartofHaydarpaşa Numune Medical Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectGene Expressionen_US
dc.subjectOX40en_US
dc.subjectPituitary Adenomasen_US
dc.titleOX40 gene expression level on pathology sections obtained from pituitary adenomas tissuesen_US
dc.typearticleen_US
dc.contributor.departmentBalıkesir Üniversitesien_US
dc.identifier.volume63en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.endpage7en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.buozeltrdizinidealen_US]
dc.department-tempSağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi, Çam ve Sakura Şehir Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiye Sağlık Bilimleri Üniversitesi Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi Nöroşirurji Anabilim Dalı, İstanbul, Türkiye Balıkesir Üniversitesi Tıp Fakültesi Nöroşirürji Anabilim Dalı, Balıkesir, Türkiye Sağlık Bilimleri Üniversitesi, Bakırköy Doktor Sadi Konuk Eğitim ve Araştırma Hastanesi, Nöroşirürji Anabilim Dalı, İstanbul, Türkiyeen_US
dc.identifier.trdizinid1176024en_US
dc.identifier.doi10.14744/hnhj.2022.99076


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess